Qiagen Q1 Revenues Grow 12 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Wednesday that revenues for the first quarter rose 12 percent year over year driven by double-digit growth in all regions and led by the Molecular Diagnostics and Applied Testing customer classes.

The company also announced organization changes with the creation of two new business areas and changes in leadership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.